Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 30 Oct 2025

Tumor regression grade predicts recurrence-free survival in intermediate-advanced hepatocellular carcinoma after conversion therapy

in Cancer Immunity and Immunotherapy

Haili Zhang
Tongshu Yang
Luping Huang
Bo Li
Hongwei Xu
Yonggang Wei

Frontiers in Immunology

doi 10.3389/fimmu.2025.1704239

329 views

Original Research

Published on 30 Oct 2025

A masking clamp for conditional activation of therapeutic antibodies

in Cancer Immunity and Immunotherapy

Adrian Bloch
Jan Felix Zimmermann
Jan Habermann
Evelyn Ullrich
Harald Kolmar

Frontiers in Immunology

doi 10.3389/fimmu.2025.1640427

147 views

Review

Published on 30 Oct 2025

Mitochondria-targeted strategies in tumor immunity

in Cancer Immunity and Immunotherapy

Xudong Cheng
Yian Wang
Bryon Johnson
Ming You

Frontiers in Immunology

doi 10.3389/fimmu.2025.1646138

103 views

Brief Research Report

Published on 30 Oct 2025

Immune suppression in MTAP-deficient cancers via glutamate metabolism and CXCL10 downregulation

in Cancer Immunity and Immunotherapy

Wen-Hsin Chang
Jun Zhang
Qi-Sheng Hong
Ching-Hsien Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1634342

170 views

Review

Published on 30 Oct 2025

Circulating plasma cells: from basic mechanisms to clinical applications

in Cancer Immunity and Immunotherapy

Pingping Wang
Nan Su
Xiaojing Yan
Feng Xu
Yan Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1674088

138 views

Case Report

Published on 30 Oct 2025

Response to anaplastic lymphoma kinase inhibitor in gastric cancer harboring DCTN1–ALK fusion: a case report and review

in Cancer Immunity and Immunotherapy

Huadi Wang
Liangkun You
Hong Pan
Xiaotong Qiu
Jin Sheng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1686666

164 views

Review

Published on 30 Oct 2025

Immunotherapy of chimeric antigen receptor NK cells: status and its promising future

in Cancer Immunity and Immunotherapy

Fang Wang
Zhaoyuan Huang
Xiaoming Feng
Mingxia Shi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1608277

185 views

Systematic Review

Published on 30 Oct 2025

Inflammatory markers from routine blood tests predict survival in multiple myeloma: a Systematic Review and meta-analysis

in Cancer Immunity and Immunotherapy

Mengjiao Luo
Ling Qin
Yujie Li
Qianru Mei
Qiaoping Wu
Xudong Feng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1669878

426 views

Original Research

Published on 30 Oct 2025

Multi-omics analysis revealed potential use of immunotherapy and CDK4/6 inhibitors in intimal sarcoma

in Cancer Immunity and Immunotherapy

Bei Wang
Rongrong Chen
Huan Yin
Ziyi Chang
Yao Liu
Dingrong Zhong
Feng Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1668537

163 views

Original Research

Published on 30 Oct 2025

Cholesterol metabolism shapes immune low-response states in LUAD: a multi-omics cholesterol metabolism signature predicts immunotherapy benefit and identifies DHCR7 as a therapeutic target

in Cancer Immunity and Immunotherapy

Mingjun Du
Jianan Zheng
Guangyao Zhou
Yu Zhuang
Chenjun Huang
Wei Ye

Frontiers in Immunology

doi 10.3389/fimmu.2025.1696360

100 views

Original Research

Published on 30 Oct 2025

Anti-OLA1 autoantibody is a potential early diagnostic marker for hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Wenzhuo Xiong
Xuehui Duan
Liping Dai
Peng Wang
Hua Ye
Jianxiang Shi
Keyan Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1647809

100 views

Review

Published on 30 Oct 2025

Sulforaphane in cancer precision medicine: from biosynthetic origins to multiscale mechanisms and clinical translation

in Cancer Immunity and Immunotherapy

Zhipeng Zhao
Qianyue Chen
Xinyu Qiao
Jianjiang Wang
Zaid Tala Abdulqader Ali
Jun Li
Ling Yin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1702860

138 views

Original Research

Accepted on 29 Oct 2025

Two vs three cycles of neoadjuvant immunochemotherapy for resectable non-small-cell lung cancer: A Real-World Population-Based Study

in Cancer Immunity and Immunotherapy

Jiawei Xiu
Xin Yao
Ying Sun
Shaopeng Xu
Chao Wang
Hongtao Duan
Xiaolong Yan

Frontiers in Immunology

Case Report

Accepted on 29 Oct 2025

Cases series of immune checkpoint inhibitor induced cholestatic hepatitis, acute renal injury and asymptomatic pancreatic enzyme elevation simultaneously

in Cancer Immunity and Immunotherapy

Rui Jiao
Chenyu Wang
Hongyan Ying
Muwen Nie
Jing Leng
Yuan Liu
Zhiyang Zhang
Na Zhou
Chunmei Bai

Frontiers in Immunology

Original Research

Accepted on 29 Oct 2025

Immune Cell Profiling of Peripheral Blood in Long-Term Testicular Germ Cell Tumor Survivors

in Cancer Immunity and Immunotherapy

Kristína Kilíková
Andrea Mlčáková
Zuzana Šestáková
Katarina Kalavska
Kristýna Adámiková
Jana Obertová
Patrik Palacka
Katarina Rejlekova
Zuzana Syčová-Milá
Valentina De Angelis

Frontiers in Immunology

Review

Accepted on 29 Oct 2025

Bidirectional regulation of lipid metabolism and the tumor microenvironment: new perspectives from mechanism to therapy

in Cancer Immunity and Immunotherapy

Kaixin Shi
Bing Pan
Ruixin Zheng
Kaiyi Liu
Jincheng Song
Xiaobo Wang
Li LI

Frontiers in Immunology